Clinical Advances in
Progressive fibrosing interstitial lung diseases (ILDs)—including idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and others—can be challenging to identify, treat, and effectively monitor in practice. However, diagnostic and treatment approaches are fast evolving, and best practice is changing. Experts in this curriculum will address how the latest data can be applied to practice to reduce the rates of morbidity and mortality for these highly burdensome conditions.
Supported by an independent educational grant from
Steering Committee Chair
Professor
University of Lyon
Hôpital Louis Pradel
Lyon, France
Professor
Department of Rheumatology
University
Hospital Zurich
Zurich, Switzerland
Rheumatologist
University Hospital of Oslo
Oslo, Norway
Thoracic Radiologist
NIHR Clinician Scientist
Imperial College London
London, United Kingdom
Director
Division of Respirology
Department of Medicine
McMaster University
Hamilton, Ontario, Canada
Department of Pulmonology
Hannover Medical School
Hannover, Germany